Baxter To Sell CVG's Products In Fringe International Markets After Spin-off
This article was originally published in The Gray Sheet
Executive Summary
Baxter Healthcare will continue to distribute products produced by its Cardiovascular Group spin-off in several countries outside of the U.S., including Argentina, Australia, Greece, Ireland, New Zealand and certain Scandinavian countries, after CVG Controlled, Inc. becomes a separate entity in the first half of 2000.